a good and interesting read: By Sue Chang, MarketWatch

New Post Public Reply Private Reply Replies (1) Message Board
truebeliever
467
a good and interesting read:

By Sue Chang, MarketWatch
Synchronized global growth further boosts the case for strong U.S. gains
Success breeds success and strength begets more strength--that will likely be the overriding theme for stocks going forward as strong fundamentals, positive sentiment and favorable seasonality keep an already pumped-up market on a steady adrenaline rush.
All major indexes closed at records this week (http://www.marketwatch.com/story/dow-aims-for-fresh-record-as-stock-futures-climb-ahead-of-us-jobs-report-2017-11-03) with the Dow Jones Industrial Average and the S&P 500 logging eight straight weekly gains, the longest for both since November 2013. The Nasdaq also notched its 63rd closing record in 2017, the most ever in a single year, according to the WSJ Market Data Group.
Ian Winer, head of equities at Wedbush, said it was technically a very bullish week, particularly for the Dow, which tested new highs almost every day.
Now a potent mix of looming tax cuts along with robust earnings may be setting stocks up for what could be a truly spectacular finale to a memorable year.
1. "I'm just a bill, yes, I'm only a bill": The Republicans on Thursday unveiled their ambitious tax package, which proposes lowering the corporate tax rate to 20%, a one-time tax break on repatriation of profits parked overseas, and a revision of the individual tax brackets (http://www.marketwatch.com/story/here-are-the-winners-and-losers-of-the-tax-plan-by-income-bracket-2017-11-03).
Experts say the outcome of tax reforms remains uncertain given the level of resistance among interest groups and the disarray within the Republican party. However, they were cautiously optimistic that the tax bill will result in some economic stimulus when it eventually passes.
Bricklin Dwyer, senior economist for U.S. and Canada at BNP Paribas, projected the tax plan could ultimately pave the way for fiscal stimulus that could add as much as 0.6 percentage point to 2018 gross domestic product growth.
See also: The Trump tax calculator -- will you pay more or less? (http://www.marketwatch.com/story/the-new-trump-tax-calculator-what-do-you-owe-2017-10-26)
Meanwhile, Joseph Song, U.S. economist at Bank of America Merrill Lynch, predicted that there will be no fiscal stimulus given that the tax bill will not pass in its current form.
"The biggest constraint for Congress is the price tag. Reconciliation directives only allow Congress to add up to $1.5 trillion to the deficit over 10 years. If the bill cost more than that, it will run afoul of the Senate reconciliation rules," said Song in a report.
The economist expects significant opposition to the bill from moderate Republicans and deficit hawks.
"We remain skeptical that a comprehensive tax plan will pass Congress but it is possible that a pared down version passes sometime early next year. Our baseline forecast currently assumes no fiscal stimulus but there is an upside risk that a small plan is enacted which would provide a modest boost," he said.
Lewis Alexander, chief U.S. economist at Nomura, believes there is a 60% probability of a simple tax package passing, 20% chance of a full-scale reform, and 20% likelihood of the tax bill failing to pass.
2. Summer blockbuster: It has been a blowout quarter for earnings, with companies reporting profits that are 4.8% better than estimates and sales 1.2% above estimates, according to latest data from FactSet.
As of late October, S&P 500 earnings are up by 4.7% with six of the 11 sectors turning in higher profits. Some 76% of companies are posting better-than-expected results, ahead of the one-year (71%) and the five-year (69%) averages, said Brad McMillan, chief investment officer for Commonwealth Financial Network.
S&P 500 revenues are also up 5.7% with 10 of the 11 sectors reporting higher sales, he said.
3. Timing is everything: Stocks are heading into the strongest couple of months of the year, particularly for the S&P 500.
According to Frank Cappelleri, a technical strategist at Instinet LLC, the S&P 500 has been higher in November 60% of the time for an average gain of 0.67% going back as far as 1928, while in the past two decades, the large-cap index been higher 15 out of 20 Novembers with an average rise of 1.5%.
"Difficulty is one thing that the SPX has not witnessed in 2017," said Cappelleri, who pointed out that the S&P 500 has risen for each month of the typically weak period spanning May to October.
4. Scale tips in favor of bulls: Richard Hastings, macro strategist at Seaport Global, noted that aside from bullish sentiment, which soared to 45% in a recent American Association of Individual Investors survey, other positive developments such as job growth, hopes for tax cuts, and higher crude-oil prices are coming into focus.
"This is a very constructive situation for the big picture investment story. We could be going into a brief period of piling up, where sentiment ignores valuation and sticks to momentum. The FANG [Facebook, Amazon, Netflix and Alphabet's Google] rebound in recent days is probably a great big 'We Are Open' sign to investors," he said.
The persistently buoyant sentiment "engineers" volatility and inefficiency out of the market and helps to shield stocks from frequent corrections, according to Hastings.
The Bank of America Merrill Lynch's Sell Side Indicator--the bank's barometer for Wall Street's bullishness on stocks--also edged up to 55.9, hovering near its highest level since 2011.
5. It's a small world after all: One of the most interesting traits about the current stock market's epic run is that it's not just the U.S. setting the world on fire but a concerted international effort.
As Jeffrey Saut, chief investment strategist at Raymond James, highlighted in his report, with major countries in synchronized expansion mode, global growth is projected to reach 3.6% in 2017 and 3.7% in 2018, the best since the Great Recession.
Torsten Slok, chief international economist at Deutsche Bank Securities, this week also shared the chart above that showed that the number of countries in a recession at a historic low, a clear sign that global economy is booming.
This uniform expansion has helped to spark a global rally in equities with the MSCI All Country World Index gaining for a record 12 straight months.
The previous longest streak was 11 months that ended in February 2004 following a drop of 50%, according to Jeffrey Kleintop, chief global investment strategist at Charles Schwab & Co.


ok, note no. 5... "that global economy is booming"
so... owcp--get it going in Germany and spread the success from there... imho ....

OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links

OWCP Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 302

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 377

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 180

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 464

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 322

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 360

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 405

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Fibocom Unveils U6G Solutions Advancing Global 5G Tech

Updated Category News Views 80

Breaking Barriers with U6G-Capable Technology Sneaking into the industry's spotlight at MWC Doha 2026, Fibocom flaunts a robust lineup of next-gen 5G solutions. It's as if they're shuffling every card they’ve got to win over the broadband world. With breakthroughs like the FG390, FG370, and FG670 modules, alongside PCBA-level innovations, Fibocom is not just throwing...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 182

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 146

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading

Top 5 Most Recently Viewed Articles

Prodigy Processing Solutions Leads the Charge in Cannabis Extraction

Updated Category News Views 240

Prodigy Processing Solutions Steps into New York's Cannabis Scene Prodigy Processing Solutions is making strides in the cannabis industry by teaming up with ProXtracts Processing Inc., a leading cannabis oil producer, to initiate a pioneering hydrocarbon extraction lab. This collaboration highlights Prodigy's commitment to providing top-notch extraction technologies while...

Continue Reading
Key Details for Moderna Investors Regarding Class Action

Updated Category News Views 69

Important Information for Moderna, Inc. Investors The Gross Law Firm has an important update for shareholders of Moderna, Inc. (NASDAQ: MRNA). If you've purchased shares during the specific class period, you're encouraged to reach out to the firm about possibly serving as lead plaintiffs in an upcoming class action lawsuit. Class Period and Lead Plaintiff Information If...

Continue Reading
Vistagen Therapeutics Investors: Important Legal Update Ahead

Updated Category News Views 117

Vistagen Therapeutics' Legal Challenges: A Summary for Investors As a prominent player in the therapeutic landscape, Vistagen Therapeutics, Inc. (NASDAQ: VTGN) is currently navigating significant legal challenges that investors should be aware of. Legal representation is crucial for those who have invested in the company's stock, particularly following the announcement of...

Continue Reading
Nilfisk Holding A/S Unveils Key 2025 Financial Dates

Updated Category News Views 494

Nilfisk Holding A/S Financial Calendar for 2025 Nilfisk Holding A/S stands out as a prominent global player in the professional cleaning industry, consistently delivering high-quality products and services. As the new year approaches, the company has set forth significant dates for financial disclosures that are vital for investors and stakeholders alike. Upcoming Key...

Continue Reading
Exciting Return of Twang’s Signature Beer and Pickle Salts

Updated Category News Views 332

Exciting Announcement from Twang Twang, a beloved Latino-founded brand, has once again captured the hearts of flavor enthusiasts. Known for its innovative and enticing blends of flavored salts, Twang is thrilled to share the return of two highly anticipated products: Orange Beer Salt and Hot Pickle Flavored Salt. Fans of these tasty seasonings can look forward to their...

Continue Reading